Skip to main content
. 2018 Apr 6;11:683–691. doi: 10.2147/JPR.S158695

Figure 2.

Figure 2

Time-course (minutes) showing the percentage of animals with analgesia after treatment with 0.5% BVC plain solution or encapsulated into alginate–chitosan nanoparticles (BVCALG) as evaluated by the infraorbital nerve blockade test in rats (n=7/group).

Abbreviations: BVC, bupivacaine; BVCALG, 0.5% bupivacaine-loaded alginate–chitosan nanoparticles.